Story

Lanxess Shares Tumble After Berenberg Downgrade to 'Sell'

ENTHMSVIIDZHZH-TWJAKOHI
Aug 13, 20262 min read
Lanxess Shares Tumble After Berenberg Downgrade to 'Sell'
Text size
Background

Shares of Lanxess (LXSG) plunged on Tuesday, pressured by a recent analyst downgrade that compounded investor concerns over the German specialty chemical company's weak earnings and cautious outlook.

The stock was trading down approximately 6.2% at €14.955, extending a decline that began after its recent quarterly report.

Analyst Downgrade Triggers Sell-Off

The immediate catalyst for the sharp decline was a research note from Berenberg, where analyst Sebastian Bray downgraded Lanxess stock from Hold to Sell. The note, issued in the prior session, also slashed the price target on the shares from €17.00 to €13.80.

According to Berenberg, consensus expectations for an earnings recovery are "excessively optimistic." The analyst also highlighted the company's balance sheet as a "significant liability," signaling to investors that financial risks may outweigh the potential for a near-term rebound.

Weak Fundamentals Magnify Concerns

Sample IUX Markets – In-articleAd

The downgrade landed on an already fragile fundamental backdrop. On August 7, Lanxess reported its second-quarter 2026 results, which included a per-share loss of -€0.62. Following the release, the stock broke below its 200-day moving average, a key technical indicator that often signals a bearish trend.

Company leadership provided little reassurance. CEO Matthias Zachert cautioned at the time that there was "no sign of a sustained upturn in core market demand" and that no further economic momentum was anticipated through the end of the year. This commentary has weighed heavily on investor sentiment.

Broader Sector Headwinds

Lanxess is not alone in its struggles, as the broader European chemicals sector faces significant challenges. Competitors including Evonik Industries, Wacker Chemie, and Brenntag also traded lower, reflecting persistent headwinds from soft industrial end-markets and rising competitive pressure from Asian producers.

With U.S. equity benchmarks trading flat, there was no broader market lift to offset the company-specific and sector-wide pressures. Now trading well below its 52-week high of €25.88, investors are reassessing the timing and likelihood of a credible earnings recovery for Lanxess.

Read next

More on Stocks
Back to latest news

LATEST